BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2026 8:53:15 AM | Browse: 1 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 119275
Country China
Received
2026-01-26 07:02
Peer-Review Started
2026-01-26 07:03
First Decision by Editorial Office Director
2026-01-29 08:40
Return for Revision
2026-01-29 08:40
Revised
2026-02-11 09:18
Publication Fee Transferred
2026-02-13 00:32
Second Decision by Editor
2026-03-26 02:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-03-26 07:15
Articles in Press
2026-03-26 07:15
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-05-11 01:37
Publish the Manuscript Online
2026-05-20 08:53
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Orthopedics
Manuscript Type Basic Study
Article Title Identification of SRSF2 as a potential immunodiagnostic biomarker for osteosarcoma: A study based on focused protein microarray
Manuscript Source Unsolicited Manuscript
All Author List Yan Ma, Lei Wan, Yong-Yong Zhang, Ya-Ge Luo, Ning Yang, Fei-Fei Pu, Malik Ihsan Ullah Khan, Man Liu, Jin-Shan Liu and Ji-Tian Li
ORCID
Author(s) ORCID Number
Yan Ma http://orcid.org/0000-0002-1148-9572
Lei Wan http://orcid.org/0000-0002-4263-0903
Yong-Yong Zhang http://orcid.org/0000-0003-2996-4789
Ya-Ge Luo http://orcid.org/0000-0002-2335-910X
Ning Yang http://orcid.org/0000-0003-0038-0368
Fei-Fei Pu http://orcid.org/0000-0001-6529-6605
Malik Ihsan Ullah Khan http://orcid.org/0000-0001-9238-6649
Man Liu http://orcid.org/0000-0002-5448-6144
Jin-Shan Liu http://orcid.org/0009-0005-4156-6240
Ji-Tian Li http://orcid.org/0000-0001-5449-8084
Funding Agency and Grant Number
Funding Agency Grant Number
China Association of Chinese Medicine Young Talent Support Program 2021-QNCRC2-A06
the Traditional Chinese Medicine Research in Henan Province 2023ZY2136
Research Project of China Information Association of Traditional Chinese Medicine CACMS-KY-2023030-2023030
Henan Province Collaborative Research Project on Traditional Chinese Medicine Science and Technology Special Program 2025LHZX5043
Corresponding Author Ji-Tian Li, MD, PhD, Professor, Henan Provincial Health Commission Key Laboratory of Bone Metabolism and Analysis, Luoyang Orthopedic Hospital of Henan Province (Orthopedic Hospital of Henan Province), Henan University of Chinese Medicine, No. 100 Yongping Road, Zhengzhou 450046, Henan Province, China. jitianlee@hotmail.com
Key Words Osteosarcoma; Tumor associated antigen; Protein microarray; Detection; SRSF2; Biomarker
Core Tip Osteosarcoma (OS) is, a common malignant tumor, with no specific serological biomarker for early diagnosis. In this study, we focused on identifying novel autoantibodies against tumor associated antigens using the focused protein microarray based on cancer-driving genes for detecting OS. Three tumor associated antigens were identified through the focused protein microarray. Expression of these three autoantibodies was further detected by enzyme-linked immunosorbent assay, which was further validated by western blotting and immunohistochemistry. Serine/arginine-rich splicing factor 2 was identified as a potential serological biomarker for OS, and a possible supplementary screening approach.
Publish Date 2026-05-20 08:53
Citation

Ma Y, Wan L, Zhang YY, Luo YG, Yang N, Pu FF, Khan MIU, Liu M, Liu JS, Li JT. Identification of SRSF2 as a potential immunodiagnostic biomarker for osteosarcoma: A study based on focused protein microarray. World J Clin Oncol 2026; 17(5): 119275

URL https://www.wjgnet.com/2218-4333/full/v17/i5/119275.htm
DOI https://dx.doi.org/10.5306/wjco.v17.i5.119275
Full Article (PDF) WJCO-17-119275-with-cover.pdf
Manuscript File 119275_Auto_Edited_133639.docx
Answering Reviewers 119275-answering-reviewers.pdf
Audio Core Tip 119275-audio.m4a
Biostatistics Review Certificate 119275-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 119275-conflict-of-interest-statement.pdf
Copyright License Agreement 119275-copyright-assignment.pdf
Institutional Review Board Approval Form or Document 119275-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 119275-non-native-speakers.pdf
Supplementary Material 119275-supplementary-material.pdf
Peer-review Report 119275-peer-reviews.pdf
Scientific Misconduct Check 119275-scientific-misconduct-check.png
Scientific Editor Work List 119275-scientific-editor-work-list.pdf
CrossCheck Report 119275-crosscheck-report.pdf